These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6425354)

  • 1. Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.
    Barry AL; Miller GH; Hare RS; Jones RN; Thornsberry C
    J Clin Microbiol; 1984 Mar; 19(3):311-4. PubMed ID: 6425354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netilmicin disk susceptibility tests: effect of cations on the MIC correlates.
    Barry AL; Miller GH; Hare RS; Thornsberry C; Jones RN
    Eur J Clin Microbiol; 1987 Aug; 6(4):416-7. PubMed ID: 3117533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.
    Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1980 Sep; 18(3):487-90. PubMed ID: 7425615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
    Barry AL; Miller GH; Thornsberry C; Hare RS; Jones RN; Lorber RR; Ferraresi R; Cramer C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1981 May; 13(5):1000-3. PubMed ID: 6787072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of 327 clinical isolates to netilmicin.
    Digranes A; Ostervold B; Madsen ST; Solberg CO; Haeger K
    J Int Med Res; 1978; 6(5):409-13. PubMed ID: 100353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.
    Barry AL; Thornsberry C; Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1980 Oct; 18(4):616-21. PubMed ID: 7447420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.
    Woolfrey BF; Fox JM; Quall CO; Lally RT
    Antimicrob Agents Chemother; 1983 Nov; 24(5):764-70. PubMed ID: 6419674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity testing of Pseudomonas aeruginosa against netilmicin and gentamicin: aminoglycosides revisited.
    Taylor ME; Brogan TD
    J Infect; 1991 Mar; 22(2):209-11. PubMed ID: 1902863
    [No Abstract]   [Full Text] [Related]  

  • 12. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
    Clark RB; Sanders CC; Pakiz CB; Hostetter MK
    Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of netilmicin, gentamicin, and amikacin.
    Kantor RJ; Norden CW
    Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
    Meyer RD; Draus LL; Pasieczinik KA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of gentamicin and netilmicin including a regression line for netilmicin.
    Bang J; Mortensen I; Bentzon MW
    Scand J Infect Dis Suppl; 1980; Suppl 23():34-8. PubMed ID: 6782656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
    Knothe H; Krcméry V
    Chemotherapy; 1979; 25(1):23-9. PubMed ID: 105839
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of carbenicillin, ticarcillin, sisomicin and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Watanakunakorn C; Glotzbecker C
    Chemotherapy; 1978; 24(6):343-6. PubMed ID: 100282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE
    J Clin Microbiol; 1982 May; 15(5):769-76. PubMed ID: 6212595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility studies with netilmicin: comparison of a 10-microgram netilmicin disk with a standardized 10-microgram gentamicin disk.
    Habwe V; Shadomy S
    Antimicrob Agents Chemother; 1978 Jun; 13(6):1046-8. PubMed ID: 98106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.